Relationship Between Exposure to Phenols and Pregnancy Outcomes After Embryo Transfer

NCT ID: NCT06767202

Last Updated: 2025-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-14

Study Completion Date

2025-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to explore the association between phenol exposure and pregnancy outcome after embryo transfer. The main question it aims to answer \[is/are\]:

Whether exposure to phenols is associated with adverse pregnancy outcomes in pregnant women undergoing assisted reproductive technology?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

First of all, paper questionnaires were used in this study, including general information questionnaire, health effect questionnaire, health survey summary form, and dietary assessment questionnaire. Secondly, obtain the relevant information of the medical record system, including: assisted reproduction protocol, IVF examination results, B-ultrasound examination results, laboratory test indicators, pregnancy outcome information and newborn information. Finally, urine samples were detected using a high performance liquid chromatography mass spectrometer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Embryo Transfer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant women undergoing assisted reproductive technology in Tongji Hospital, Wuhan City, Hubei Pro

1. Chinese citizens over the age of 20;
2. IVF/ICSI assisted reproductive treatment in our center;
3. Complete clinical data, reproductive outcomes and questionnaire data of both sexes;
4. Knowing about this research and voluntarily accepting this research;

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Chinese citizens over the age of 20;
2. IVF/ICSI assisted reproductive treatment in our center;
3. Complete clinical data, reproductive outcomes and questionnaire data of both sexes;
4. Knowing about this research and voluntarily accepting this research;

Exclusion Criteria

1. The patient receives sperm or egg donation treatment;
2. The patient gave up the egg collection operation due to various reasons, and the cycle was canceled;
3. The patient abandons treatment before achieving clinical pregnancy, but the fertile frozen embryo is not transferred;
4. There are contraindications to pregnancy, such as serious liver and kidney diseases, malignant tumors, serious mental diseases, uncorrected coagulation function abnormalities or endocrine indicators abnormalities;
5. Incomplete or missing clinical data or follow-up data;
Minimum Eligible Age

20 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

keqin liu

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

keqin liu

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Reproductive center,tongji hospital,huazhong university of science and technology

Wuhan, Hubei, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

liukeqin0208

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.